FDA provides clarity for cell and gene therapy development
The U.S. FDA issued final guidance establishing a comprehensive potency assurance strategy for cellular and gene therapy product manufacturers.
The U.S. FDA issued final guidance establishing a comprehensive potency assurance strategy for cellular and gene therapy product manufacturers.